9p21 locus polymorphism is a strong predictor of metabolic syndrome and cardiometabolic risk phenotypes regardless of coronary heart disease

HIGHLIGHTS

  • who: Muhammad Mobeen Zafar et al. from the University Institute of Biochemistry and Biotechnology, PMAS-Arid Agriculture University, Department of Pathology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil have published the Article: 9p21 Locus Polymorphism Is A Strong Predictor of Metabolic Syndrome and Cardiometabolic Risk Phenotypes Regardless of Coronary Heart Disease, in the Journal: Genes 2022, 2226 of 27/09/2018
  • what: This study was designed to explore the association of the minor/risk allele (C) of 9p21 SNP rs1333049 with MetS or its risk phenotypes regardless of an established CHD . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?